RU2015132569A - Полимиксины, композиции с ними, способы получения и способы применения - Google Patents

Полимиксины, композиции с ними, способы получения и способы применения Download PDF

Info

Publication number
RU2015132569A
RU2015132569A RU2015132569A RU2015132569A RU2015132569A RU 2015132569 A RU2015132569 A RU 2015132569A RU 2015132569 A RU2015132569 A RU 2015132569A RU 2015132569 A RU2015132569 A RU 2015132569A RU 2015132569 A RU2015132569 A RU 2015132569A
Authority
RU
Russia
Prior art keywords
hplc
octanoyl
methyl
composition
methylheptanoyl
Prior art date
Application number
RU2015132569A
Other languages
English (en)
Russian (ru)
Inventor
Сёльви ГУННЕС
Видар БЬЁРНСТАД
Торбен Кох
Клес Меландер
Мартин МОНССОН
Original Assignee
Кселлия Фармасьютикалз Апс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кселлия Фармасьютикалз Апс filed Critical Кселлия Фармасьютикалз Апс
Publication of RU2015132569A publication Critical patent/RU2015132569A/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62Polymyxins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
RU2015132569A 2013-01-11 2014-01-09 Полимиксины, композиции с ними, способы получения и способы применения RU2015132569A (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361751341P 2013-01-11 2013-01-11
US61/751,341 2013-01-11
US201361904793P 2013-11-15 2013-11-15
US61/904,793 2013-11-15
PCT/EP2014/050320 WO2014108469A1 (en) 2013-01-11 2014-01-09 Polymyxins, compositions, methods of making and methods of use

Publications (1)

Publication Number Publication Date
RU2015132569A true RU2015132569A (ru) 2017-02-14

Family

ID=50101865

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015132569A RU2015132569A (ru) 2013-01-11 2014-01-09 Полимиксины, композиции с ними, способы получения и способы применения

Country Status (20)

Country Link
US (1) US10640536B2 (OSRAM)
EP (1) EP2943503B1 (OSRAM)
JP (1) JP6316846B2 (OSRAM)
KR (1) KR20150107793A (OSRAM)
CN (1) CN104918951B (OSRAM)
AU (1) AU2014204873B2 (OSRAM)
BR (1) BR112015016548A2 (OSRAM)
CA (1) CA2895910C (OSRAM)
EA (1) EA027067B1 (OSRAM)
ES (1) ES2641017T3 (OSRAM)
HU (1) HUE034562T2 (OSRAM)
IL (1) IL239840A (OSRAM)
MX (1) MX360905B (OSRAM)
PT (1) PT2943503T (OSRAM)
RU (1) RU2015132569A (OSRAM)
SI (1) SI2943503T1 (OSRAM)
TW (1) TWI613219B (OSRAM)
UA (1) UA117673C2 (OSRAM)
WO (1) WO2014108469A1 (OSRAM)
ZA (1) ZA201504565B (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA027067B1 (ru) 2013-01-11 2017-06-30 Кселлия Фармасьютикалз Апс Полимиксины, композиции, способы получения и способы применения
TW201522364A (zh) * 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉(cms)之定性方法
JP2017523953A (ja) 2014-07-09 2017-08-24 クセリア ファーマシューティカルズ エーピーエスXellia Pharmaceuticals ApS 低置換度ポリミキシン及びその組成物
RS60874B1 (sr) 2014-10-03 2020-11-30 Xellia Pharmaceuticals Aps Kompozicije
SG11201702666SA (en) 2014-10-03 2017-04-27 Xellia Pharmaceuticals Aps Inhalation device
WO2016100578A2 (en) 2014-12-16 2016-06-23 Micurx Pharmaceuticals, Inc. Antimicrobial polymyxins for treatment of bacterial infections
FI126143B (en) * 2015-01-15 2016-07-15 Northern Antibiotics Oy Polymyxine derivative and its uses
AU2016331658B2 (en) * 2015-09-29 2021-04-01 Monash University Antimicrobial polymyxin derivative compounds
CN109996806B (zh) * 2016-12-09 2021-11-02 正大天晴药业集团股份有限公司 高效价的多黏菌素e2甲磺酸钠
CN115298198A (zh) 2020-01-21 2022-11-04 上海盟科药业股份有限公司 用于肾相关癌症靶向治疗的新型化合物和组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1062895A (en) 1962-12-13 1967-03-22 Wellcome Found Sulphomethyl derivatives of polymxin
FR1586834A (OSRAM) 1968-02-12 1970-03-06
DE1906699A1 (de) 1968-02-12 1970-02-05 Pfizer Neue Polymyxinderivate und Verfahren zu deren Herstellung
EP0362370A1 (en) * 1988-04-07 1990-04-11 Edward Shanbrom Non-thrombogenic intravascular time release catheter
ATE202481T1 (de) 1996-11-15 2001-07-15 Pathogenesis Corp Reines, biologisch aktives colistin, seine bestandteile und eine colistin-zubereitung zur behandlung von entzündungen der atemwege
US5767068A (en) 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
ES2261735T3 (es) 2001-05-18 2006-11-16 Chiron Corporation Sistema para la administracion de una formulacion de tobramicina.
US20040022740A1 (en) 2001-07-10 2004-02-05 Baker William R. Macrolide formulations for inhalation and methods of treatment of endobronchial infections
EP1940859A1 (en) * 2005-10-28 2008-07-09 Arch Pharmalabs Limited An improved process for preparation of gemcitabine hydrochloride
WO2008025560A1 (en) 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
US20080066739A1 (en) 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
WO2012168820A1 (en) 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
EA027067B1 (ru) 2013-01-11 2017-06-30 Кселлия Фармасьютикалз Апс Полимиксины, композиции, способы получения и способы применения
TW201522364A (zh) 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉(cms)之定性方法
JP2017523953A (ja) 2014-07-09 2017-08-24 クセリア ファーマシューティカルズ エーピーエスXellia Pharmaceuticals ApS 低置換度ポリミキシン及びその組成物
RS60874B1 (sr) 2014-10-03 2020-11-30 Xellia Pharmaceuticals Aps Kompozicije

Also Published As

Publication number Publication date
KR20150107793A (ko) 2015-09-23
EP2943503A1 (en) 2015-11-18
CN104918951A (zh) 2015-09-16
ES2641017T3 (es) 2017-11-07
JP2016505007A (ja) 2016-02-18
SI2943503T1 (sl) 2017-11-30
CA2895910A1 (en) 2014-07-17
US10640536B2 (en) 2020-05-05
MX360905B (es) 2018-11-21
TW201429995A (zh) 2014-08-01
US20160002296A1 (en) 2016-01-07
CA2895910C (en) 2021-12-21
UA117673C2 (uk) 2018-09-10
AU2014204873A1 (en) 2015-07-09
AU2014204873B2 (en) 2017-07-06
MX2015008878A (es) 2015-10-30
IL239840A (en) 2017-09-28
IL239840A0 (en) 2015-08-31
EA201591280A1 (ru) 2015-12-30
HUE034562T2 (en) 2018-03-28
JP6316846B2 (ja) 2018-04-25
EA027067B1 (ru) 2017-06-30
EP2943503B1 (en) 2017-08-23
CN104918951B (zh) 2018-03-30
TWI613219B (zh) 2018-02-01
WO2014108469A1 (en) 2014-07-17
ZA201504565B (en) 2016-11-30
PT2943503T (pt) 2017-09-28
BR112015016548A2 (pt) 2017-07-11

Similar Documents

Publication Publication Date Title
RU2015132569A (ru) Полимиксины, композиции с ними, способы получения и способы применения
JP2016505007A5 (OSRAM)
AR121016A2 (es) Sales de fenotiazindiaminio y su uso
MX385731B (es) Compuestos de biaril-monobactam y métodos de uso de los mismos para el tratamiento de infecciones bacterianas.
EA201891103A1 (ru) Композиции для лечения спинальной мышечной атрофии
EA201800064A1 (ru) 1,1,1-трифтор-3-гидроксипропан-2-ил карбаматные производные и 1,1,1-трифтор-4-гидроксибутан-2-ил карбаматные производные в качестве ингибиторов magl
RU2015138796A (ru) Способы и составы для лечения респираторных заболеваний
FI3616695T3 (fi) Menetelmät keuhkojen sisäisten infektioiden hoitamiseksi
EA202090604A1 (ru) Хроманмонобактамовые соединения для лечения бактериальных инфекций
JP2017510580A5 (OSRAM)
EA201490864A1 (ru) Производные (4-фенилимидазол-2-ил)этиламина в качестве модуляторов натриевых каналов
HRP20171512T1 (hr) Derivati betulina
JP2016503052A5 (OSRAM)
BR112014004704A2 (pt) compostos antibacterianos e métodos de uso
JP2013542992A5 (OSRAM)
EA201790337A1 (ru) Кристаллические формы ингибиторов глутаминазы
HRP20200938T1 (hr) Kombinacija koja sadrži zidovudin i polimiksin
EA201890771A1 (ru) Соли и твердые формы монобактамного антибиотика
EA201590022A1 (ru) Новые производные 1,3-дигидро-2h-бензимидазол-2-она, замещенные гетероциклами, в качестве противовирусных средств против респираторного синцитиального вируса
EA202091118A1 (ru) Антибактериальные соединения
RU2017141536A (ru) Замещенные производные индол-5-ола и их терапевтические применения
EA201791138A1 (ru) Фармацевтическая композиция, ее приготовление и применения
ME02405B (me) Spojevi pirazola као inhibitori sglt1
EA201691271A1 (ru) Соединения [1 ,2,4]триазоло[1 ,5-a]пиримидина в качестве ингибиторов протозойной протеосомы для лечения паразитарного заболевания, такого как лейшманиоз
EA201792264A1 (ru) Способы лечения воспалительных заболеваний

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20171109